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Programmable rate detection in automatic defibrillators 
(IACD) is designed to prevent asymptomatic shocixs (AS) 
from supraventricular tachycardia. To deterl!;rine if 
programmable rate d 
consecutive patients 
Group I 4/W pt's had at least 1 
16/40 had AS (pc.OS). The number of total shocks 
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A greater proportion (58% vs. 21 ) of AS occurred in 
Group II. 'The decrease in AS persisted when adjusted 
for length of follow up. The decrease in AS 
due to AW node blocking'drugs. The overall mortality at 
1 year was the same in both groups. Thus, rate 
programmability appears to decrease the proportion of 
AS in patients with IACDs. 
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Individual DFT increases over the first three months were as much as 238 
Volts, a 77% increase in voltage, or 13.5 Joules, a 204% increase in stored 
energy. The results of this study show that DFTs can rise substantially from 
baseline values with some individuals manifesting marked changes. The 
trend is for the DFT to rise end peak early after implant falling to lower 
values thereafter yet remaining higher than the implant DFI’ for at least 
three months. 
We conclude that DFPs are dynamic and may be affected by changes 
in the lead-tissue interface. Multiprogrammable antiarrhythmia devices 
should be programmed to a minimum defibrillation energy output of at least 
twice the implant DFI' value to ensure defibrillation cnronically. Post 
implant evaluation of defibrillation efficacy is recommended in order to 
optimize long-term device function. 
